1122 related articles for article (PubMed ID: 15837766)
1. Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells.
Uddin S; Hussain AR; Al-Hussein KA; Manogaran PS; Wickrema A; Gutierrez MI; Bhatia KG
Clin Cancer Res; 2005 Apr; 11(8):3102-8. PubMed ID: 15837766
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of phosphatidylinositol 3'-kinase induces preferentially killing of PTEN-null T leukemias through AKT pathway.
Uddin S; Hussain A; Al-Hussein K; Platanias LC; Bhatia KG
Biochem Biophys Res Commun; 2004 Jul; 320(3):932-8. PubMed ID: 15240138
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of phosphatidylinositol-3 kinase/Akt or mitogen-activated protein kinase signaling sensitizes endothelial cells to TNF-alpha cytotoxicity.
Zhang L; Himi T; Morita I; Murota S
Cell Death Differ; 2001 May; 8(5):528-36. PubMed ID: 11423913
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the PI3K-Akt signaling pathway enhances the sensitivity of Fas-mediated apoptosis in human gastric carcinoma cell line, MKN-45.
Osaki M; Kase S; Adachi K; Takeda A; Hashimoto K; Ito H
J Cancer Res Clin Oncol; 2004 Jan; 130(1):8-14. PubMed ID: 14605879
[TBL] [Abstract][Full Text] [Related]
5. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process.
Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S
Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569
[TBL] [Abstract][Full Text] [Related]
6. Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma.
Hideshima T; Nakamura N; Chauhan D; Anderson KC
Oncogene; 2001 Sep; 20(42):5991-6000. PubMed ID: 11593406
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation and nuclear exclusion of the forkhead transcription factor FKHR after epidermal growth factor treatment in human breast cancer cells.
Jackson JG; Kreisberg JI; Koterba AP; Yee D; Brattain MG
Oncogene; 2000 Sep; 19(40):4574-81. PubMed ID: 11030146
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of phosphatidylinositol-3/Akt-kinase inhibition on apoptotic sensitization to cytokines in LNCaP and PCc-3 prostate cancer cells.
Beresford SA; Davies MA; Gallick GE; Donato NJ
J Interferon Cytokine Res; 2001 May; 21(5):313-22. PubMed ID: 11429162
[TBL] [Abstract][Full Text] [Related]
9. Activation of the Akt/FKHRL1 pathway mediates the antiapoptotic effects of erythropoietin in primary human erythroid progenitors.
Uddin S; Kottegoda S; Stigger D; Platanias LC; Wickrema A
Biochem Biophys Res Commun; 2000 Aug; 275(1):16-9. PubMed ID: 10944433
[TBL] [Abstract][Full Text] [Related]
10. PI3-kinase regulates survival of chronic lymphocytic leukemia B-cells by preventing caspase 8 activation.
Plate JM
Leuk Lymphoma; 2004 Aug; 45(8):1519-29. PubMed ID: 15370202
[TBL] [Abstract][Full Text] [Related]
11. Cross-talk between NFkB and the PI3-kinase/AKT pathway can be targeted in primary effusion lymphoma (PEL) cell lines for efficient apoptosis.
Hussain AR; Ahmed SO; Ahmed M; Khan OS; Al Abdulmohsen S; Platanias LC; Al-Kuraya KS; Uddin S
PLoS One; 2012; 7(6):e39945. PubMed ID: 22768179
[TBL] [Abstract][Full Text] [Related]
12. Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells.
Pfeil K; Eder IE; Putz T; Ramoner R; Culig Z; Ueberall F; Bartsch G; Klocker H
Prostate; 2004 Feb; 58(3):259-68. PubMed ID: 14743465
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of paclitaxel cytotoxicity in lung and esophageal cancer cells by pharmacologic inhibition of the phosphoinositide 3-kinase/protein kinase B (Akt)-mediated signaling pathway.
Nguyen DM; Chen GA; Reddy R; Tsai W; Schrump WD; Cole G; Schrump DS
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):365-75. PubMed ID: 14762343
[TBL] [Abstract][Full Text] [Related]
14. Oxidant-mediated Akt activation in human RPE cells.
Yang P; Peairs JJ; Tano R; Jaffe GJ
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4598-606. PubMed ID: 17003457
[TBL] [Abstract][Full Text] [Related]
15. Constitutive activation of phosphatidyl-inositide 3 kinase contributes to the survival of Hodgkin's lymphoma cells through a mechanism involving Akt kinase and mTOR.
Dutton A; Reynolds GM; Dawson CW; Young LS; Murray PG
J Pathol; 2005 Mar; 205(4):498-506. PubMed ID: 15714459
[TBL] [Abstract][Full Text] [Related]
16. The PI3-kinase-Akt pathway promotes mesangial cell survival and inhibits apoptosis in vitro via NF-kappa B and Bad.
Shimamura H; Terada Y; Okado T; Tanaka H; Inoshita S; Sasaki S
J Am Soc Nephrol; 2003 Jun; 14(6):1427-34. PubMed ID: 12761242
[TBL] [Abstract][Full Text] [Related]
17. Growth inhibition of human malignant glioma cells induced by the PI3-K-specific inhibitor.
Shingu T; Yamada K; Hara N; Moritake K; Osago H; Terashima M; Uemura T; Yamasaki T; Tsuchiya M
J Neurosurg; 2003 Jan; 98(1):154-61. PubMed ID: 12546364
[TBL] [Abstract][Full Text] [Related]
18. Migrating glioma cells activate the PI3-K pathway and display decreased susceptibility to apoptosis.
Joy AM; Beaudry CE; Tran NL; Ponce FA; Holz DR; Demuth T; Berens ME
J Cell Sci; 2003 Nov; 116(Pt 21):4409-17. PubMed ID: 13130092
[TBL] [Abstract][Full Text] [Related]
19. Sensitisation of HL60 human leukaemic cells to cytotoxic drug-induced apoptosis by inhibition of PI3-kinase survival signals.
O'Gorman DM; McKenna SL; McGahon AJ; Knox KA; Cotter TG
Leukemia; 2000 Apr; 14(4):602-11. PubMed ID: 10764145
[TBL] [Abstract][Full Text] [Related]
20. GSK-3beta reactivation with LY294002 sensitizes hepatoma cells to chemotherapy-induced apoptosis.
Beurel E; Kornprobst M; Blivet-Van Eggelpoël MJ; Cadoret A; Capeau J; Desbois-Mouthon C
Int J Oncol; 2005 Jul; 27(1):215-22. PubMed ID: 15942663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]